Your browser doesn't support javascript.
loading
Double-bright (CD56bright/CD16bright) natural killer cell adoptive immunotherapy for SARS-CoV-2.
Silla, Lúcia.
Affiliation
  • Silla L; Hematologia e Hemoterapia, Hospital de Clínicas, Porto Alegre, Brazil.
Br J Haematol ; 190(6): e322-e323, 2020 09.
Article in En | MEDLINE | ID: mdl-32645204
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / CD56 Antigen / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Br J Haematol Year: 2020 Document type: Article Affiliation country: Brasil
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Killer Cells, Natural / CD56 Antigen / SARS-CoV-2 / COVID-19 / COVID-19 Drug Treatment Limits: Humans Language: En Journal: Br J Haematol Year: 2020 Document type: Article Affiliation country: Brasil